Business Description
Laboratory Corp of America Holdings
NAICS : 621511
SIC : 8071
ISIN : BRL1CABDR006
Share Class Description:
BSP:L1CA34: BRDRDescription
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.8 | |||||
| Debt-to-EBITDA | 3.27 | |||||
| Interest Coverage | 7.89 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.16 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.5 | |||||
| 3-Year EBITDA Growth Rate | 10.3 | |||||
| 3-Year EPS without NRI Growth Rate | 25.1 | |||||
| 3-Year FCF Growth Rate | 15 | |||||
| 3-Year Book Growth Rate | 13.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -4.18 | |||||
| Future 3-5Y Total Revenue Growth Rate | -6.49 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.86 | |||||
| 9-Day RSI | 58.5 | |||||
| 14-Day RSI | 59.2 | |||||
| 6-1 Month Momentum % | -6.25 | |||||
| 12-1 Month Momentum % | -16.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.36 | |||||
| Quick Ratio | 1.2 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 14.82 | |||||
| Days Sales Outstanding | 48.91 | |||||
| Days Payable | 24.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.36 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| Forward Dividend Yield % | 1.36 | |||||
| 5-Year Yield-on-Cost % | 1.36 | |||||
| 3-Year Average Share Buyback Ratio | 3.2 | |||||
| Shareholder Yield % | 1.57 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.2 | |||||
| Operating Margin % | 10 | |||||
| Net Margin % | 4.18 | |||||
| FCF Margin % | 6.07 | |||||
| ROE % | 7.01 | |||||
| ROA % | 3.49 | |||||
| ROIC % | 7.66 | |||||
| ROC (Joel Greenblatt) % | 32.1 | |||||
| ROCE % | 7.86 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.09 | |||||
| Forward PE Ratio | 15.11 | |||||
| PE Ratio without NRI | 16.24 | |||||
| Shiller PE Ratio | 17.1 | |||||
| Price-to-Owner-Earnings | 120.37 | |||||
| PEG Ratio | 1.15 | |||||
| PS Ratio | 1.22 | |||||
| PB Ratio | 2.35 | |||||
| Price-to-Free-Cash-Flow | 20.05 | |||||
| Price-to-Operating-Cash-Flow | 13.77 | |||||
| EV-to-EBIT | 18.82 | |||||
| EV-to-Forward-EBIT | 13.77 | |||||
| EV-to-EBITDA | 12.42 | |||||
| EV-to-Forward-EBITDA | 11.52 | |||||
| EV-to-Revenue | 1.51 | |||||
| EV-to-Forward-Revenue | 1.95 | |||||
| EV-to-FCF | 24.99 | |||||
| Price-to-Projected-FCF | 0.85 | |||||
| Price-to-DCF (Earnings Based) | 0.71 | |||||
| Price-to-DCF (FCF Based) | 0.96 | |||||
| Price-to-Median-PS-Value | 0.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.51 | |||||
| Earnings Yield (Greenblatt) % | 5.32 | |||||
| FCF Yield % | 5.22 | |||||
| Forward Rate of Return (Yacktman) % | 17.92 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Laboratory Corp of America Holdings Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 80,670.172 | ||
| EPS (TTM) (R$) | 9.417 | ||
| Beta | -0.19 | ||
| Volatility % | 18.99 | ||
| 14-Day RSI | 59.2 | ||
| 14-Day ATR (R$) | 2.462587 | ||
| 20-Day SMA (R$) | 260.86 | ||
| 12-1 Month Momentum % | -16.35 | ||
| 52-Week Range (R$) | 244.57 - 335.66 | ||
| Shares Outstanding (Mil) | 339.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Laboratory Corp of America Holdings Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Laboratory Corp of America Holdings Stock Events
| Event | Date | Price(R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Laboratory Corp of America Holdings Frequently Asked Questions
What is Laboratory Corp of America Holdings(BSP:L1CA34)'s stock price today?
The current price of BSP:L1CA34 is R$267.03. The 52 week high of BSP:L1CA34 is R$335.66 and 52 week low is R$244.57.
When is next earnings date of Laboratory Corp of America Holdings(BSP:L1CA34)?
The next earnings date of Laboratory Corp of America Holdings(BSP:L1CA34) is 2024-02-16 Est..
Does Laboratory Corp of America Holdings(BSP:L1CA34) pay dividends? If so, how much?
The Dividend Yield %  of Laboratory Corp of America Holdings(BSP:L1CA34) is 1.36% (As of Today), Highest Dividend Payout Ratio of Laboratory Corp of America Holdings(BSP:L1CA34) was 0.3. The lowest was 0.13. And the median was 0.13. The  Forward Dividend Yield % of Laboratory Corp of America Holdings(BSP:L1CA34) is 1.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers